Enzo: Enzo Biochem, Inc. Reports Earnings Results for the First Quarter Ended October 31, 2024

Enzo Biochem, Inc. reported earnings results for the first quarter ended October 31, 2024. For the first quarter, the company reported sales was USD 6.21 million compared to USD 7.81 million a year ago. Net loss was USD 3.38 million compared to USD 6.62 million a year ago. Basic loss per share from continuing operations was USD 0.07 compared to USD 0.11 a year ago. Diluted loss per share from continuing operations was USD 0.07 compared to USD 0.11 a year ago. Basic loss per share was USD 0.07 compared to USD 0.13 a year ago. Diluted loss per share was USD 0.07 compared to USD 0.13 a year ago.